A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine
Public ClinicalTrials.gov record NCT06616194. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
AN INTERVENTIONAL, EFFICACY, AND SAFETY, PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY WITH AN OPEN-LABEL EXTENSION TO INVESTIGATE RIMEGEPANT IN MIGRAINE PREVENTION IN ADOLESCENTS 12 TO LESS THAN 18 YEARS OF AGE WITH CHRONIC MIGRAINE
Study identification
- NCT ID
- NCT06616194
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Pfizer
- Industry
- Enrollment
- 200 participants
Conditions and interventions
Conditions
Interventions
- Placebo Drug
- Rimegepant Drug
Drug
Eligibility (public fields only)
- Age range
- 12 Years to 17 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 14, 2024
- Primary completion
- Oct 7, 2026
- Completion
- Dec 1, 2027
- Last update posted
- May 4, 2026
2024 – 2027
United States locations
- U.S. sites
- 14
- U.S. states
- 8
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Adult & Child Neurology Medical Associates | Long Beach | California | 90806 | Recruiting |
| Ann & Robert H. Lurie Children's Hospital of Chicago | Chicago | Illinois | 60611 | Recruiting |
| Chicago Headache Center and Research Institute | Chicago | Illinois | 60657 | Recruiting |
| Michigan Headache & Neurological Institute | Ann Arbor | Michigan | 48104 | Recruiting |
| Clinvest Headlands Llc | Springfield | Missouri | 65807 | Recruiting |
| Rutgers University | New Brunswick | New Jersey | 08901 | Recruiting |
| OnSite Clinical Solutions | Charlotte | North Carolina | 28211 | Recruiting |
| Duke Health Center Creekstone | Durham | North Carolina | 27703 | Recruiting |
| Duke Lenox Baker Children's | Durham | North Carolina | 27705 | Recruiting |
| Wake Forest University Baptist Medical Center ( WFUBMC ) | Winston-Salem | North Carolina | 27157 | Recruiting |
| Avera Medical Group Pediatric Specialists | Sioux Falls | South Dakota | 57105 | Recruiting |
| Avera Research Institute - Sioux Falls | Sioux Falls | South Dakota | 57108 | Recruiting |
| Avera Medical Group Pediatrics - Dawley Farm | Sioux Falls | South Dakota | 57110 | Recruiting |
| The University of Texas Health Science Center at Houston | Houston | Texas | 77030 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 34 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06616194, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 4, 2026 · Synced May 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06616194 live on ClinicalTrials.gov.